TIL (STOCKS)
Instil Bio, Inc. Common Stock
$7.770000
+0.080000 (+1.04%)
Prev close: $7.690000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bronson Crouch
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $53.17M
- Employees
- 14
- P/E (TTM)
- -0.68
- P/B (TTM)
- 0.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$931.00K |
| Operating Expenses | $80.84M |
| Operating Income/Loss | -$80.84M |
| Income/Loss From Continuing Operations After Tax | -$75.08M |
| Income/Loss From Continuing Operations Before Tax | -$75.08M |
| Net Income/Loss | -$75.08M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$75.08M |
| Net Income/Loss Available To Common Stockholders, Basic | -$75.08M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$11.35 |
| Diluted Earnings Per Share | -$11.35 |
| Basic Average Shares | 6,635,245 |
| Diluted Average Shares | 6,635,245 |
| Assets | $211.77M |
| Current Assets | $196.26M |
| Noncurrent Assets | $15.50M |
| Fixed Assets | $138.00K |
| Other Non-current Assets | $15.37M |
| Liabilities | $91.35M |
| Current Liabilities | $5.70M |
| Accounts Payable | $928.00K |
| Wages | $2.09M |
| Other Current Liabilities | $2.68M |
| Noncurrent Liabilities | $85.65M |
| Equity | $120.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $120.42M |
| Liabilities And Equity | $211.77M |
| Net Cash Flow From Operating Activities | -$40.10M |
| Net Cash Flow From Operating Activities, Continuing | -$40.10M |
| Net Cash Flow From Investing Activities | $30.66M |
| Net Cash Flow From Investing Activities, Continuing | $30.66M |
| Net Cash Flow From Financing Activities | $8.89M |
| Net Cash Flow From Financing Activities, Continuing | $8.89M |
| Exchange Gains/Losses | -$26.00K |
| Net Cash Flow | -$582.00K |
| Net Cash Flow, Continuing | -$556.00K |
| Comprehensive Income/Loss | -$75.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$75.17M |
| Other Comprehensive Income/Loss | -$75.17M |
| Other Comprehensive Income/Loss Attributable To Parent | -$92.00K |